{"database": "malaria", "table": "v_malaria_current", "is_view": true, "human_description_en": "sorted by display_name", "rows": [[115, "AFG", "AF", "Afghanistan", 1, 1, 1, 1, "whole_country", "All areas <2,500 m (<8,200 ft) elevation (April\u2013December)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - All areas <2,500 m (<8,200 ft) elevation (April–December)
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (primarily)
\r\n - P. falciparum (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 115], [180, "ALB", "AL", "Albania", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 180], [1, "DZA", "DZ", "Algeria", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 1], [135, "ASM", "AS", "American Samoa (U.S.)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 135], [208, "AND", "AD", "Andorra", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 208], [26, "AGO", "AO", "Angola", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 26], [59, "AIA", "AI", "Anguilla (U.K.)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 59], [235, "ATA", "AQ", "Antarctica", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 235], [60, "ATG", "AG", "Antigua and Barbuda", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 60], [101, "ARG", "AR", "Argentina", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 101], [181, "ARM", "AM", "Armenia", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 181], [61, "ABW", "AW", "Aruba (Netherlands)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 61], [136, "AUS", "AU", "Australia", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 136], [209, "AUT", "AT", "Austria", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 209], [182, "AZE", "AZ", "Azerbaijan", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 182], [210, "PRT", "PT", "Azores (Portugal)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 210], [62, "BHS", "BS", "Bahamas, The", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 62], [165, "BHR", "BH", "Bahrain", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 165], [116, "BGD", "BD", "Bangladesh", 1, 1, 0, 1, "partial", "1 risk area statement(s); 1 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. malariae\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - Districts of Chittagong Hill Tract (Bandarban, Khagrachari, and Rangamati); and the following districts: Chattogram (Chittagong) and Cox’s Bazar (in Chattogram [Chittagong] Division); Mymensingh, Netrakona, and Sherpur (in Mymensingh Division); Kurigram (in Rangpur Division); Habiganj, Moulvibazar, Sunamganj, and Sylhet (in Sylhet Division)
\r\n - No malaria transmission in Dhaka (the capital)
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (80%)
\r\n - P. vivax (20%)
\r\n - P. malariae (rare)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 116], [63, "BRB", "BB", "Barbados", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 63], [183, "BLR", "BY", "Belarus", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 183], [211, "BEL", "BE", "Belgium", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 211], [83, "BLZ", "BZ", "Belize", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 83], [8, "BEN", "BJ", "Benin", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 8], [64, "BMU", "BM", "Bermuda (U.K.)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 64], [117, "BTN", "BT", "Bhutan", 1, 0, 0, 0, "none", "Transmission present; no chemoprophylaxis recommended (mosquito avoidance only).", "[\"P. falciparum\", \"P. vivax\"]", "[]", 1, "\r\n - Rare cases in rural areas <1,700 m (<5,500 ft) elevation in districts along the southern border shared with India
\r\n
\r\n", "\r\n - None (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (primarily)
\r\n - P. falciparum (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 117], [91, "BOL", "BO", "Bolivia", 1, 1, 0, 1, "partial", "1 risk area statement(s); 1 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"primaquine\", \"tafenoquine\"]", 1, "\r\n - All areas <2,500 m (<8,200 ft) elevation
\r\n - No malaria transmission in La Paz (administrative capital)
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, primaquine5, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (99%)
\r\n - P. falciparum (1%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 91], [238, "BES", "BQ", "Bonaire (Netherlands)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 238], [184, "BIH", "BA", "Bosnia and Herzegovina", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 184], [53, "BWA", "BW", "Botswana", 1, 1, 0, 1, "partial", "2 risk area statement(s); 1 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - Districts/subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North-East (including its capital, Francistown), Okavango, Serowe/Palapye, and Tutume
\r\n - Rare cases or sporadic foci of transmission in districts/subdistricts of Kgalagadi North, Kgatleng, Kweneng, and Southern
\r\n - No malaria transmission in Gaborone (the capital)
\r\n
\r\n", "\r\n - Districts/subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North-East (including its capital, Francistown), Okavango, Serowe/Palapye, and Tutume: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n - Areas with rare cases or sporadic foci of transmission: no chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 53], [92, "BRA", "BR", "Brazil", 1, 1, 0, 1, "partial", "3 risk area statement(s); 2 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - All areas in the states of Acre, Amapá, Amazonas, Rondônia, and Roraima
\r\n - Present in the states of Maranhão, Mato Grosso, and Pará, but rare cases in their capital cities (São Luis [capital of Maranhão], Cuiabá [capital of Mato Grosso], Belém [capital of Pará])
\r\n - Rare cases and sporadic foci of transmission in rural and forested areas in the states of Espírito Santo, Goiás, Minas Gerais, Mato Grosso do Sul, Piauí, Rio de Janeiro, São Paolo, and Tocantins
\r\n - No malaria transmission in the cities of Brasília (the capital), Rio de Janeiro, or São Paolo
\r\n - No malaria transmission at Iguaçu Falls
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n - Areas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (90%)
\r\n - P. falciparum (10%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 92], [118, "IOT", "IO", "British Indian Ocean Territory; includes Diego Garcia (U.K.)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 118], [124, "BRN", "BN", "Brunei", 1, 0, 0, 0, "none", "Transmission present; no chemoprophylaxis recommended (mosquito avoidance only).", "[\"P. knowlesi\"]", "[]", 0, "\r\n - Rare transmission of P. knowlesi6 in primarily forested or forest-fringe areas
\r\n
\r\n", "\r\n - None (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. knowlesi6 (100%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 124], [185, "BGR", "BG", "Bulgaria", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 185], [9, "BFA", "BF", "Burkina Faso", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 9], [125, "MMR", "MM", "Burma (Myanmar)", 1, 1, 1, 1, "whole_country", "All areas", "[\"P. falciparum\", \"P. knowlesi\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Areas in the regions of Bago and Tanintharyi; and in the states of Kachin, Kayah, Kayin, and Shan: Atovaquone-proguanil, doxycycline, tafenoquine2
\r\n - All other areas: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (80%)
\r\n - P. falciparum (20%)
\r\n - P. knowlesi,6 P. malariae, and P. ovale (rare)
\r\n
\r\n", "\r\n - Chloroquine and mefloquine
\r\n
\r\n", "2025-04-23", "2026-06-03", 125], [36, "BDI", "BI", "Burundi", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 36], [126, "KHM", "KH", "Cambodia", 1, 1, 0, 1, "partial", "4 risk area statement(s)", "[\"P. falciparum\", \"P. knowlesi\", \"P. malariae\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"primaquine\", \"tafenoquine\"]", 1, "\r\n - Primarily isolated to pockets in rural and forested areas
\r\n - Rare cases in non-forested areas
\r\n - No (or negligible) malaria transmission in the cities of Phnom Penh (the capital) and Siem Reap
\r\n - No (or negligible) malaria transmission at the main temple complex at Angkor Wat
\r\n
\r\n", "\r\n - Rural and forested areas: Atovaquone-proguanil, doxycycline, primaquine5, tafenoquine2
\r\n - Areas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (95%)
\r\n - P. falciparum (5%)
\r\n - P. malariae and P. knowlesi6 (rare)
\r\n
\r\n", "\r\n - Chloroquine and mefloquine
\r\n
\r\n", "2025-04-23", "2026-06-03", 126], [27, "CMR", "CM", "Cameroon", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 27], [162, "CAN", "CA", "Canada", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 162], [2, "ESP", "ES", "Canary Islands ( Spain )", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 2], [10, "CPV", "CV", "Cape Verde", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 10], [65, "CYM", "KY", "Cayman Islands (U.K.)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 65], [28, "CAF", "CF", "Central African Republic", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 28], [29, "TCD", "TD", "Chad", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 29], [102, "CHL", "CL", "Chile", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 102], [107, "CHN", "CN", "China", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 107], [137, "CXR", "CX", "Christmas Island (Australia)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 137], [138, "CCK", "CC", "Cocos (Keeling) Islands (Australia)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 138], [93, "COL", "CO", "Colombia", 1, 1, 0, 1, "partial", "1 risk area statement(s); 1 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - All areas <1,700 m (<5,600 ft) elevation
\r\n - No malaria transmission in the cities of Bogotá (the capital), Cartagena, or Medellín
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (50%)
\r\n - P. vivax (50%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 93], [37, "COM", "KM", "Comoros", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae and P. vivax (rare)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 37], [30, "COG", "CG", "Congo, Republic of the (Congo-Brazzaville)", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 30], [139, "COK", "CK", "Cook Islands (New Zealand)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 139], [84, "CRI", "CR", "Costa Rica", 1, 1, 0, 1, "partial", "2 risk area statement(s)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"chloroquine\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 0, "\r\n - Present in the provinces of Alajuela and Limón
\r\n - Rare to no transmission in other parts of the country
\r\n
\r\n", "\r\n - Alajuela and Limón Provinces: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine2
\r\n - All other areas: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (86%)
\r\n - P. vivax (14%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 84], [186, "HRV", "HR", "Croatia", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 186], [66, "CUB", "CU", "Cuba", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 66], [239, "CUW", "CW", "Cura\u00e7ao (Netherlands)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 239], [166, "CYP", "CY", "Cyprus", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 166], [187, "CZE", "CZ", "Czechia (Czech Republic)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 187], [11, "CIV", "CI", "C\u00f4te d'Ivoire (Ivory Coast)", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 11], [31, "COD", "CD", "Democratic Republic of the Congo (Congo-Kinshasa)", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 31], [212, "DNK", "DK", "Denmark", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 212], [38, "DJI", "DJ", "Djibouti", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (60–70%)
\r\n - P. vivax (30–40%)
\r\n - P. ovale (rare)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 38], [67, "DMA", "DM", "Dominica", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 67], [68, "DOM", "DO", "Dominican Republic", 1, 1, 0, 1, "partial", "3 risk area statement(s)", "[\"P. falciparum\"]", "[\"atovaquone-proguanil\", \"chloroquine\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 0, "\r\n - Primarily in the provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo
\r\n - In the Distrito Nacional, city of Santo Domingo (the capital), primarily in the La Ciénaga and Los Tres Brazos areas
\r\n - Rare transmission in other provinces
\r\n
\r\n", "\r\n - Provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine2
\r\n - All other areas: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (100%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 68], [103, "CHL", "CL", "Easter Island (Chile)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 103], [94, "ECU", "EC", "Ecuador, including the Gal\u00e1pagos Islands", 1, 1, 0, 1, "partial", "2 risk area statement(s); 2 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - Areas <1,500 m (<5,000 ft) elevation in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos
\r\n - Rare cases <1,500 m (<5,000 ft) in all other provinces
\r\n - No malaria transmission in the cities of Guayaquil or Quito (the capital)
\r\n - No malaria transmission on the Galápagos Islands
\r\n
\r\n", "\r\n - Transmission areas in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n - All other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (85%)
\r\n - P. falciparum (15%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 94], [3, "EGY", "EG", "Egypt", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 3], [85, "SLV", "SV", "El Salvador", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 85], [32, "GNQ", "GQ", "Equatorial Guinea", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 32], [39, "ERI", "ER", "Eritrea", 1, 1, 0, 1, "partial", "1 risk area statement(s); 1 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - All areas <2,200 m (<7,200 ft) elevation
\r\n - No malaria transmission in Asmara (the capital)
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (80–85%)
\r\n - P. vivax (15–20%)
\r\n - P. malariae and P. ovale (rare)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 39], [188, "EST", "EE", "Estonia", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 188], [57, "SWZ", "SZ", "Eswatini (Swaziland)", 1, 1, 0, 1, "partial", "1 risk area statement(s)", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - Eastern areas bordering Mozambique and South Africa, including the entire region of Lubombo and the eastern half of Hhohho, Manzini, and Shiselweni Regions
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 57], [40, "ETH", "ET", "Ethiopia", 1, 1, 1, 1, "whole_country", "All areas <2,500 m (<8,200 ft) elevation", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - All areas <2,500 m (<8,200 ft) elevation
\r\n
\r\n", "\r\n - All areas <2,500m (8,200 ft) elevation, including Addis Ababa: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (70%)
\r\n - P. vivax (30%)
\r\n - P. malariae and P. ovale (rare)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 40], [104, "FLK", "FK", "Falkland Islands (Islas Malvinas), UK Overseas Territory (also claimed by Argentina)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 104], [213, "FRO", "FO", "Faroe Islands (Denmark)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 213], [140, "FJI", "FJ", "Fiji", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 140], [214, "FIN", "FI", "Finland", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 214], [215, "FRA", "FR", "France", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 215], [95, "GUF", "GF", "French Guiana", 1, 1, 0, 1, "partial", "1 risk area statement(s); 2 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. malariae\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - Areas associated with gold mining, primarily the communes near the border with Brazil and Suriname, especially Régina and Saint-Georges-de-l’Oyapock; also, the communes of Kourou, Matoury, and Saint-Élie
\r\n - No malaria transmission in coastal areas west of Kourou
\r\n - No malaria transmission in Cayenne City (the capital)
\r\n
\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. vivax (85%)
\r\n - P. falciparum (15%)
\r\n - P. malariae (rare)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 95], [141, "PYF", "PF", "French Polynesia (France), including the Society Islands [Bora-Bora, Moorea & Tahiti]; Marquesas Islands [Hiva Oa & Ua Huka]; and Austral Islands (Tubuai & Rurutu)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 141], [33, "GAB", "GA", "Gabon", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 33], [12, "GMB", "GM", "Gambia, The", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 12], [189, "GEO", "GE", "Georgia", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 189], [216, "DEU", "DE", "Germany", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 216], [13, "GHA", "GH", "Ghana", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 13], [217, "GIB", "GI", "Gibraltar (U.K.)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 217], [218, "GRC", "GR", "Greece", 1, 0, 0, 0, "none", "Transmission present; no chemoprophylaxis recommended (mosquito avoidance only).", "[\"P. vivax\"]", "[]", null, "\r\n - Rare, local transmission in agricultural areas, associated with imported malaria (May–November)
\r\n - No malaria transmission in tourist\u202fareas
\r\n
\r\n", "\r\nUpdated April 23, 2025
", "\r\n", "\r\n", "2025-04-23", "2026-06-03", 218], [219, "GRL", "GL", "Greenland (Denmark)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 219], [69, "GRD", "GD", "Grenada", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 69], [70, "GLP", "GP", "Guadeloupe (including Marie-Galante, La D\u00e9sirade & \u00celes des Saintes)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 70], [142, "GUM", "GU", "Guam (U.S.)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 142], [86, "GTM", "GT", "Guatemala", 1, 1, 0, 1, "partial", "2 risk area statement(s); 2 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"chloroquine\", \"doxycycline\", \"mefloquine\", \"primaquine\", \"tafenoquine\"]", 0, "\r\n - Primarily in the departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén
\r\n - Few cases reported in other departments
\r\n - No malaria transmission in the cities of Antigua or Guatemala City (the capital)
\r\n - No malaria transmission at Lake Atitlán
\r\n
\r\n", "\r\n - Departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine2
\r\n - Other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (99%)
\r\n - P. falciparum\u202f(1%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 86], [14, "GIN", "GN", "Guinea", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 14], [15, "GNB", "GW", "Guinea-Bissau", 1, 1, 1, 1, "whole_country", "All", "[\"P. falciparum\", \"P. malariae\", \"P. ovale\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n", "\r\n - Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (primarily)
\r\n - P. malariae, P. ovale, and P. vivax (less commonly)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 15], [96, "GUY", "GY", "Guyana", 1, 1, 0, 1, "partial", "All", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 1, "\r\n - All
\r\n - Rare cases in the cities of Georgetown (the capital) and New Amsterdam
\r\n
\r\n", "\r\n - All areas (except the cities of Georgetown and New Amsterdam): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
\r\n - Cities of Georgetown and Amsterdam: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (60%)
\r\n - P. falciparum (40%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 96], [71, "HTI", "HT", "Haiti", 1, 1, 1, 1, "whole_country", "All (including Labadee, also known as Port Labadee)", "[\"P. falciparum\", \"P. malariae\"]", "[\"atovaquone-proguanil\", \"chloroquine\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 0, "\r\n - All (including Labadee, also known as Port Labadee)
\r\n
\r\n", "\r\n - Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
", "\r\n - P. falciparum (99%)
\r\n - P. malariae (rare)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 71], [87, "HND", "HN", "Honduras", 1, 1, 0, 1, "partial", "1 risk area statement(s); 1 no-transmission exclusion(s)", "[\"P. falciparum\", \"P. vivax\"]", "[\"atovaquone-proguanil\", \"chloroquine\", \"doxycycline\", \"mefloquine\", \"tafenoquine\"]", 0, "\r\n - Throughout the country and on the island of Roatán and other Bay Islands
\r\n - No malaria transmission in the cities of San Pedro Sula or Tegucigalpa (the capital)
\r\n
\r\n", "\r\n - Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine2
\r\n
\r\nUpdated April 23, 2025
\r\n", "\r\n - P. vivax (70%)
\r\n - P. falciparum (30%)
\r\n
\r\n", "\r\n", "2025-04-23", "2026-06-03", 87], [108, "HKG", "HK", "Hong Kong (China)", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 108], [190, "HUN", "HU", "Hungary", 0, 0, 0, 0, "none", null, "[]", "[]", null, null, "", "", "", null, "2026-06-03", 190]], "truncated": false, "filtered_table_rows_count": 244, "expanded_columns": [], "expandable_columns": [], "columns": ["country_id", "iso3", "iso2", "display_name", "has_transmission", "is_endemic", "whole_country_endemic", "country_has_any_prophylaxis_area", "screening_class", "area_summary", "species_json", "prophylaxis_drugs_json", "chloroquine_resistant", "area_of_risk_html", "recommended_prophylaxis_html", "species_html", "chloroquine_resist_html", "cdc_updated_date", "first_seen_on", "record_id"], "primary_keys": [], "units": {}, "query": {"sql": "select country_id, iso3, iso2, display_name, has_transmission, is_endemic, whole_country_endemic, country_has_any_prophylaxis_area, screening_class, area_summary, species_json, prophylaxis_drugs_json, chloroquine_resistant, area_of_risk_html, recommended_prophylaxis_html, species_html, chloroquine_resist_html, cdc_updated_date, first_seen_on, record_id from v_malaria_current order by display_name limit 101", "params": {}}, "facet_results": {"screening_class": {"name": "screening_class", "type": "column", "hideable": false, "toggle_url": "/malaria/v_malaria_current.json", "results": [{"value": "none", "label": "none", "count": 161, "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?screening_class=none", "selected": false}, {"value": "whole_country", "label": "whole_country", "count": 47, "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?screening_class=whole_country", "selected": false}, {"value": "partial", "label": "partial", "count": 36, "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?screening_class=partial", "selected": false}], "truncated": false}, "chloroquine_resistant": {"name": "chloroquine_resistant", "type": "column", "hideable": false, "toggle_url": "/malaria/v_malaria_current.json", "results": [{"value": 1, "label": 1, "count": 78, "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?chloroquine_resistant=1", "selected": false}, {"value": 0, "label": 0, "count": 10, "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?chloroquine_resistant=0", "selected": false}], "truncated": false}, "has_transmission": {"name": "has_transmission", "type": "column", "hideable": false, "toggle_url": "/malaria/v_malaria_current.json", "results": [{"value": 0, "label": 0, "count": 154, "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?has_transmission=0", "selected": false}, {"value": 1, "label": 1, "count": 90, "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?has_transmission=1", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "is_endemic", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=is_endemic"}, {"name": "whole_country_endemic", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=whole_country_endemic"}, {"name": "country_has_any_prophylaxis_area", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=country_has_any_prophylaxis_area"}, {"name": "area_summary", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=area_summary"}, {"name": "species_json", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=species_json"}, {"name": "prophylaxis_drugs_json", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=prophylaxis_drugs_json"}, {"name": "chloroquine_resist_html", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=chloroquine_resist_html"}, {"name": "cdc_updated_date", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=cdc_updated_date"}, {"name": "first_seen_on", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet=first_seen_on"}, {"name": "cdc_updated_date", "type": "date", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet_date=cdc_updated_date"}, {"name": "first_seen_on", "type": "date", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet_date=first_seen_on"}, {"name": "species_json", "type": "array", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet_array=species_json"}, {"name": "prophylaxis_drugs_json", "type": "array", "toggle_url": "http://malariatracker.com/malaria/v_malaria_current.json?_facet_array=prophylaxis_drugs_json"}], "next": "100", "next_url": "http://malariatracker.com/malaria/v_malaria_current.json?_next=100", "private": false, "allow_execute_sql": true, "query_ms": 25.080017745494843, "source": "CDC Travelers' Health (Yellow Fever & Malaria, by country)", "source_url": "https://wwwnc.cdc.gov/travel/Services/xmlservices.asmx/YellowFeverInformationJson", "license": "Public Domain (CDC)", "license_url": "https://www.cdc.gov/other/agencymaterials.html"}